share_log

Medifast Analyst Ratings

Benzinga ·  Oct 13, 2023 16:59
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/13/2023 19.05% Stephens & Co. → $82 Initiates Coverage On → Equal-Weight
08/08/2023 16.14% DA Davidson $93 → $80 Maintains Neutral
07/31/2023 35.02% DA Davidson $75 → $93 Maintains Neutral
05/02/2023 3.08% DA Davidson $94 → $71 Maintains Neutral
02/22/2023 36.47% DA Davidson $106 → $94 Maintains Neutral
11/04/2022 53.89% DA Davidson $278 → $106 Downgrades Buy → Neutral
08/04/2022 303.6% DA Davidson $352 → $278 Maintains Buy
08/04/2022 117.77% Jefferies $345 → $150 Downgrades Buy → Hold
06/02/2022 411.03% DA Davidson $341 → $352 Maintains Buy
02/24/2022 395.06% DA Davidson $349 → $341 Maintains Buy
11/08/2021 406.68% DA Davidson $395 → $349 Maintains Buy
05/05/2021 473.46% DA Davidson $302 → $395 Maintains Buy
02/26/2021 338.44% DA Davidson $239 → $302 Maintains Buy
01/25/2021 284.73% Jefferies $205 → $265 Upgrades Hold → Buy
01/12/2021 246.98% DA Davidson $205 → $239 Maintains Buy
11/05/2020 197.62% DA Davidson $180 → $205 Upgrades Neutral → Buy
06/25/2020 138.1% B. Riley Securities → $164 Initiates Coverage On → Buy
05/06/2020 24.85% DA Davidson $83 → $86 Maintains Neutral
02/27/2020 20.5% DA Davidson $74 → $83 Maintains Neutral
11/08/2019 7.43% DA Davidson $250 → $74 Downgrades Buy → Neutral
07/25/2019 88.73% Jefferies → $130 Initiates Coverage On → Buy
02/27/2019 213.59% Sidoti & Co. $211 → $216 Maintains Buy
11/08/2018 Sidoti & Co. Upgrades Neutral → Buy

What is the target price for Medifast (MED)?

The latest price target for Medifast (NYSE: MED) was reported by Stephens & Co. on October 13, 2023. The analyst firm set a price target for $82.00 expecting MED to rise to within 12 months (a possible 19.05% upside). 6 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Medifast (MED)?

The latest analyst rating for Medifast (NYSE: MED) was provided by Stephens & Co., and Medifast initiated their equal-weight rating.

When is the next analyst rating going to be posted or updated for Medifast (MED)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medifast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medifast was filed on October 13, 2023 so you should expect the next rating to be made available sometime around October 13, 2024.

Is the Analyst Rating Medifast (MED) correct?

While ratings are subjective and will change, the latest Medifast (MED) rating was a initiated with a price target of $0.00 to $82.00. The current price Medifast (MED) is trading at is $68.88, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment